Huaiwen Chen

1.4k citations
31 papers · 1.2k indexed · h-index 20
Topics
RNA Interference and Gene Delivery (15 papers)Nanoparticle-Based Drug Delivery (11 papers)Cancer Cells and Metastasis (6 papers)
Partner nations
ChinaIndiaTaiwan

In The Last Decade

Huaiwen Chen

30 papers receiving 1.2k citations

Peers

Huaiwen Chen
Comparison fields: 5 of 101
  • Molecular Biology 657
  • Biomaterials 564
  • Biomedical Engineering 437
  • Oncology 222
  • Immunology 118
Replace Yingjuan Lu with:
Yingjuan Lu United States
Michael Teifel Germany
Xinghai Li United States
Alexandros Marios Sofias Germany
Lia Appold Germany
Bryan Hoang Canada
Jan‐Niklas May Germany
Rui Ran China
Paula Ofek Israel
Zhongyu Jiang China
Huaiwen Chen relative to Yingjuan Lu United States Yingjuan Lu's profile →
Citations per field
00.5×1.5×
Yingjuan Lu · 1×
Citations per year

Countries citing papers authored by Huaiwen Chen

Since Specialization
Citations

This map shows the geographic impact of Huaiwen Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huaiwen Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huaiwen Chen more than expected).

Fields of papers citing papers by Huaiwen Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huaiwen Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huaiwen Chen. The network helps show where Huaiwen Chen may publish in the future.

Co-authorship network of co-authors of Huaiwen Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Huaiwen Chen. A scholar is included among the top collaborators of Huaiwen Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huaiwen Chen. Huaiwen Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 9
2 21
3 30
4 60
5 45
6 15
7 39
8 102
9 44
10 77
11 25
12 95
13 110
14 102
15 19
16 66
17 47
18 36
19
Development of Internet Based Remote Health and Activity Monitoring Systems for the Elders
6
20 6

About Huaiwen Chen

Huaiwen Chen is a scholar working on Biomaterials, Biotechnology and Immunology, having authored 31 papers that have together received 1.2k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (15 papers), Nanoparticle-Based Drug Delivery (11 papers) and Cancer Cells and Metastasis (6 papers). The work is most often cited by research in Biomaterials (564 citations), Pharmaceutical Science (66 citations) and Biomedical Engineering (437 citations). Huaiwen Chen has collaborated with scholars based in China, India and Taiwan. Frequent co-authors include Jie Gao, Yajun Guo, Weizhu Qian, Jianxin Dai, Yongsheng Yu, Bohua Li, Geng Kou, Yu Xia, Zuochong Yu and Yingying Zhang. Their work appears in journals such as Biomaterials, Advanced Functional Materials and Journal of Controlled Release.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026